At a glance
ClinicalIndex Comparison RecordN/ACompleted· 107 enrolled
Drug / intervention
Comparison of pain intensity rating scaleother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Comparison of Two Different Techniques of Remifentanil Consumption During Implantable Vascular Access Device Procedures
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital·interventional·Posted Feb 10, 2021·Updated Feb 10, 2021
In Brief
A clinical study evaluating Comparison of pain intensity rating scale for Opioid Use, Unspecified and 5 related conditions. Completed, enrolled 107 participants across 2 sites.
Detailed Summary
Our aim was to investigate whether remifentanil use in both infusion and bolus techniques could provide sufficient sedation and analgesia without serious adverse effects for central venous access device procedures under monitored anesthesia care.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid Use, Unspecified, Remifentanil, Sedation Complication, Analgesia, Satisfaction, Patient, Vascular Access Complication
CountriesTurkey (Türkiye)
CollaboratorsTrakya University
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2012
Primary CompletionApr 2020
Study CompletionJun 2020
First PostedFeb 2021
TodayJul 2026
First PostedFeb 10, 2021
Enrollment StartAug 1, 2012
Primary CompletionApr 30, 2020
Study CompletionJun 30, 2020
TodayJul 2, 2026
Enrollment to primary: 7.7 yearsPosted 5.4 years ago
Interventions
Comparison of pain intensity rating scaleother
Comparison of numerical pain intensity rating scale Comparison of faces pain rating scale Comparison of consumption of total amount of remifentanil